News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,698 Results
Type
Article (8066)
Company Profile (140)
Press Release (476491)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166800)
Career Advice (306)
Deals (25749)
Drug Delivery (8)
Drug Development (52909)
Employer Resources (14)
FDA (9763)
Job Trends (8579)
News (238309)
Policy (17925)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33165)
ALS (104)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (262)
Approvals (10373)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3634)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47874)
Collaboration (1240)
Commercialization (3)
Compensation (1452)
Complete response letters (34)
COVID-19 (757)
CRISPR (63)
C-suite (740)
Cystic fibrosis (85)
Data (5630)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73702)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87594)
Executive appointments (699)
FDA (12376)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (912)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9317)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (945)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12395)
IRA (2)
Job creations (1969)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (506)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (530)
Marketing (8)
MASH (118)
Medical device (8652)
Medtech (8792)
Mergers & acquisitions (14381)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1820)
NextGen: Class of 2026 (3153)
Non-profit (841)
Now hiring (1)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (503)
Peanut (31)
People (41225)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15465)
Phase 2 (21377)
Phase 3 (14410)
Pipeline (7264)
Policy (18)
Postmarket research (1571)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3021)
Recruiting (6)
Regulatory (14805)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2022)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (18)
Weight loss (73)
Women's health (78)
Date
Today (52)
Last 7 days (423)
Last 30 days (1629)
Last 365 days (19084)
2026 (12132)
2025 (19256)
2024 (22994)
2023 (26547)
2022 (34608)
2021 (37177)
2020 (33509)
2019 (23263)
2018 (17468)
2017 (18767)
2016 (17918)
2015 (24271)
2014 (21681)
2013 (18139)
2012 (20224)
2011 (20447)
2010 (20335)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17894)
Australia (2100)
California (11916)
Canada (3131)
China (520)
Colorado (482)
Connecticut (408)
Delaware (210)
Europe (24653)
Florida (1783)
Georgia (376)
Hawaii (3)
Idaho (46)
Illinois (696)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1199)
Massachusetts (7835)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2615)
New Mexico (12)
New York (2814)
North Carolina (1270)
North Dakota (4)
Northern California (5965)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2246)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4947)
Tennessee (119)
Texas (1930)
United States (38734)
Utah (358)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (923)
West Virginia (1)
Wisconsin (74)
484,698 Results for "lyell immunopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
August 6, 2026
·
16 min read
Press Releases
Lyell Immunopharma Announces Participation in May 2026 Investor Conferences
May 12, 2026
·
2 min read
Press Releases
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 25, 2026
·
2 min read
Press Releases
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026
·
2 min read
Press Releases
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
May 7, 2026
·
13 min read
Press Releases
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
·
2 min read
Press Releases
Lyell Immunopharma Announces Participation in March 2026 Investor Conferences
February 23, 2026
·
2 min read
Press Releases
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
June 5, 2026
·
3 min read
Press Releases
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
June 14, 2026
·
8 min read
Press Releases
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
March 13, 2026
·
19 min read
1 of 48,470
Next
